Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Norepinephrine Bitartrate Injection

Approval Number

国药准字H20243326

Company成都欣捷高新技术开发股份有限公司

Registration Date

March 12, 2024

Drug Information

Generic Name

重酒石酸去甲肾上腺素注射液

Dosage Form

注射剂

Strength

1ml∶2mg

Drug Type

化学药品

Registration Date

March 12, 2024

Company Information

Applicant Company

Company Name成都欣捷高新技术开发股份有限公司

Company Address

成都高新区冯家湾工业园科园南路88号B7栋5楼

Manufacturing Company

Company Name四川美大康佳乐药业有限公司

Company Address

成都高新区西部园区西芯大道15号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

重酒石酸去甲肾上腺素注射液 - NMPA 批准文号 | MedPath